ACOR

Acorda Therapeutics, Inc. News Headlines

$35.25
*  
0.52
 negative 
1.45%
Get ACOR Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases
4/23/2014 8:48:00 AM - Seeking Alpha

Hot Stocks: Hot Stocks to Watch
4/14/2014 9:35:00 AM - Dow Jones Business News

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 1:35:00 PM - Seeking Alpha

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 11:54:36 AM - SeekingAlpha

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 11:54:00 AM - Seeking Alpha

Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha

From Lab Bench To Bedside: David Lowe Brings Common Sense To Neuroscience Investing
3/30/2014 7:38:00 AM - Seeking Alpha

Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape
3/5/2014 10:18:01 AM - Zacks.com

Acorda Therapeutics: Long-Term Fundamentals Look Promising
2/22/2014 12:53:00 PM - Seeking Alpha

Acorda Up After Q4 Earnings - Analyst Blog
2/18/2014 3:53:01 PM - Zacks.com

Acorda Therapeutics To Present At Leerink Global Conference; Webcast At 11:35AM
2/13/2014 10:36:00 AM - RTT News

Sector Update: Healthcare
2/13/2014 9:53:27 AM - MT Newswires

Sector Update: Healthcare Shares Fairly Flat; Acorda Q4 Earnings Top Street View
2/13/2014 9:52:59 AM - MT Newswires

Acorda Q4 Revenue Rises
2/13/2014 6:59:00 AM - RTT News

Will Zoetis (ZTS) Miss Estimates in Q4? - Analyst Blog
2/10/2014 1:50:01 PM - Zacks.com

Ram Selvaraju: A Pair Of Companies Ride The Sea Change In Cancer Therapeutics
2/7/2014 2:22:00 PM - Seeking Alpha

Is The Healthcare Sector Pulling Back Or Crashing?
1/28/2014 5:40:00 AM - Seeking Alpha

Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
1/21/2014 7:19:00 AM - Seeking Alpha

Acorda Therapeutics, Inc. (ACOR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/17/2014 8:00:01 AM - Zacks.com

ACOR Preliminary Q4 Revs Look Good - Analyst Blog
1/14/2014 12:40:01 PM - Zacks.com

Positive Data on Incyte's Jakafi - Analyst Blog
12/10/2013 6:23:49 PM - Zacks.com

Another R&D Failure for Eli Lilly - Analyst Blog
12/6/2013 12:05:29 PM - Zacks.com

MDCO Acquires Rempex - Analyst Blog
12/5/2013 12:05:28 PM - Zacks.com

BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape
12/4/2013 9:37:01 AM - Zacks.com

Biogen's Hemophilia B Drug Approval Delayed - Analyst Blog
12/3/2013 5:50:01 PM - Zacks.com